{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T07:11:07Z","timestamp":1780470667903,"version":"3.54.1"},"reference-count":102,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,6,9]],"date-time":"2021-06-09T00:00:00Z","timestamp":1623196800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,6,9]],"date-time":"2021-06-09T00:00:00Z","timestamp":1623196800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002241","name":"the Japan Science and Technology Agency","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002241","id-type":"DOI","asserted-by":"crossref"}]},{"name":"JSPS KAKENHI","award":["17K19810"],"award-info":[{"award-number":["17K19810"]}]},{"name":"JSPS KAKENHI","award":["18K07387"],"award-info":[{"award-number":["18K07387"]}]},{"name":"JSPS KAKENHI","award":["19K08596"],"award-info":[{"award-number":["19K08596"]}]},{"name":"JSPS KAKENHI","award":["16K10520"],"award-info":[{"award-number":["16K10520"]}]},{"name":"JSPS KAKENHI","award":["20K17953"],"award-info":[{"award-number":["20K17953"]}]},{"name":"JSPS KAKENHI","award":["19K09451"],"award-info":[{"award-number":["19K09451"]}]},{"name":"JSPS KAKENHI","award":["17K16626"],"award-info":[{"award-number":["17K16626"]}]},{"name":"JSPS KAKENHI","award":["20K07810"],"award-info":[{"award-number":["20K07810"]}]},{"name":"the Japan Agency for Medical Research and Development"},{"name":"Setsuro Fujii Memorial, the Osaka Foundation for Promotion of Fundamental Medical Research"},{"name":"The Japan Public Health Center-based Prospective Study supported by National Cancer Center Research and Development Fund","award":["None"],"award-info":[{"award-number":["None"]}]},{"name":"Grant-in-Aid for Cancer Research from the Ministry of Health, Labour and Welfare of Japan","award":["None"],"award-info":[{"award-number":["None"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Acute ischemic stroke (AIS) is a serious cause of mortality and disability. AIS is a serious cause of mortality and disability. Early diagnosis of atherosclerosis, which is the major cause of AIS, allows therapeutic intervention before the onset, leading to prevention of AIS.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Serological identification by cDNA expression cDNA libraries and the protein array method were used for the screening of antigens recognized by serum IgG antibodies in patients with atherosclerosis. Recombinant proteins or synthetic peptides derived from candidate antigens were used as antigens to compare serum IgG levels between healthy donors (HDs) and patients with atherosclerosis-related disease using the amplified luminescent proximity homogeneous assay-linked immunosorbent assay.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The first screening using the protein array method identified death-inducer obliterator 1 (DIDO1), forkhead box J2 (FOXJ2), and cleavage and polyadenylation specificity factor (CPSF2) as the target antigens of serum IgG antibodies in patients with AIS. Then, we prepared various antigens including glutathione S-transferase-fused DIDO1 protein as well as peptides of the amino acids 297\u2013311 of DIDO1, 426\u2013440 of FOXJ2, and 607\u2013621 of CPSF2 to examine serum antibody levels. Compared with HDs, a significant increase in antibody levels of the DIDO1 protein and peptide in patients with AIS, transient ischemic attack (TIA), and chronic kidney disease (CKD) but not in those with acute myocardial infarction and diabetes mellitus (DM). Serum anti-FOXJ2 antibody levels were elevated in most patients with atherosclerosis-related diseases, whereas serum anti-CPSF2 antibody levels were associated with AIS, TIA, and DM. Receiver operating characteristic curves showed that serum DIDO1 antibody levels were highly associated with CKD, and correlation analysis revealed that serum anti-FOXJ2 antibody levels were associated with hypertension. A prospective case\u2013control study on ischemic stroke verified that the serum antibody levels of the DIDO1 protein and DIDO1, FOXJ2, and CPSF2 peptides showed significantly higher odds ratios with a risk of AIS in patients with the highest quartile than in those with the lowest quartile, indicating that these antibody markers are useful as risk factors for AIS.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Serum antibody levels of DIDO1, FOXJ2, and CPSF2 are useful in predicting the onset of atherosclerosis-related AIS caused by kidney failure, hypertension, and DM, respectively.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12916-021-02001-9","type":"journal-article","created":{"date-parts":[[2021,6,9]],"date-time":"2021-06-09T04:14:03Z","timestamp":1623212043000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Serum anti-DIDO1, anti-CPSF2, and anti-FOXJ2 antibodies as predictive risk markers for acute ischemic stroke"],"prefix":"10.1186","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0475-3881","authenticated-orcid":false,"given":"Takaki","family":"Hiwasa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken-ichiro","family":"Goto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seiichiro","family":"Mine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshio","family":"Machida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eiichi","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoichi","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiko","family":"Adachi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoo","family":"Matsutani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mizuki","family":"Sata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazumasa","family":"Yamagishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyasu","family":"Iso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norie","family":"Sawada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoichiro","family":"Tsugane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitoshi","family":"Kunimatsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ikuo","family":"Kamitsukasa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Mori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuo","family":"Sugimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiyuki","family":"Uzawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayumi","family":"Muto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Kuwabara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshio","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikiko","family":"Ohno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eiichiro","family":"Nishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiko","family":"Hattori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masashi","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiro","family":"Maezawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuki","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryoichi","family":"Ishibashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minoru","family":"Takemoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koutaro","family":"Yokote","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirotaka","family":"Takizawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Kishimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuyuki","family":"Matsushita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sohei","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumio","family":"Nomura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Arasawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiko","family":"Kagaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuro","family":"Maruyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisahiro","family":"Matsubara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minako","family":"Tomiita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinsaku","family":"Hamanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yushi","family":"Imai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoo","family":"Nakagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoya","family":"Kato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiro","family":"Terada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuma","family":"Matsumura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Katsumata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Naito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuhiro","family":"Tanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seiichiro","family":"Sakao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichiro","family":"Tatsumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaaki","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumiaki","family":"Shiratori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Sumazaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Yajima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideaki","family":"Shimada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikako","family":"Shirouzu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeyuki","family":"Yokoyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Kudo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirofumi","family":"Doi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuro","family":"Iwase","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiromi","family":"Ashino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-Yang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaaki","family":"Kubota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Go","family":"Tomiyoshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natsuko","family":"Shinmen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rika","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideyuki","family":"Kuroda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuo","family":"Iwadate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,6,9]]},"reference":[{"key":"2001_CR1","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/s41572-019-0106-z","volume":"5","author":"P Libby","year":"2019","unstructured":"Libby P, Buring JE, Badimon L, Hansson GK, Deanfield J, Bittencourt MS, et al. Atherosclerosis. Nat Rev Dis Primers. 2019;5:56. https:\/\/doi.org\/10.1038\/s41572-019-0106-z PMID: 31420554.","journal-title":"Nat Rev Dis Primers"},{"key":"2001_CR2","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1161\/ATVBAHA.119.312705","volume":"39","author":"JM Valdivielso","year":"2019","unstructured":"Valdivielso JM, Rodriguez-Puyol D, Pascual J, Barrios C, Berm\u00fadez-L\u00f3pez M, S\u00e1nchez-Ni\u00f1o MD, et al. Atherosclerosis in chronic kidney disease. Arterioscler Thromb Vasc Biol. 2019;39:1938\u201366. https:\/\/doi.org\/10.1161\/ATVBAHA.119.312705 PMID: 31412740.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2001_CR3","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1038\/s41569-019-0227-9","volume":"16","author":"GL Basatemur","year":"2019","unstructured":"Basatemur GL, J\u00f8rgensen HF, Clarke MCH, Bennett MR, Mallat Z. Vascular smooth muscle cells in atherosclerosis. Nat Rev Cardiol. 2019;16:727\u201344. https:\/\/doi.org\/10.1038\/s41569-019-0227-9 PMID: 31243391.","journal-title":"Nat Rev Cardiol"},{"key":"2001_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.vph.2017.02.004","volume":"91","author":"JR Nelson","year":"2017","unstructured":"Nelson JR, Wani O, May HT, Budoff M. Potential benefits of eicosapentaenoic acid on atherosclerotic plaques. Vascul Pharmacol. 2017;91:1\u20139. https:\/\/doi.org\/10.1016\/j.vph.2017.02.004 PMID: 28263852.","journal-title":"Vascul Pharmacol"},{"key":"2001_CR5","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.ejphar.2017.10.005","volume":"816","author":"J Nagenborg","year":"2017","unstructured":"Nagenborg J, Goossens P, Biessen EAL, Donners MMPC. Heterogeneity of atherosclerotic plaque macrophage origin, phenotype and functions: implications for treatment. Eur J Pharmacol. 2017;816:14\u201324. https:\/\/doi.org\/10.1016\/j.ejphar.2017.10.005 PMID: 28989084.","journal-title":"Eur J Pharmacol"},{"key":"2001_CR6","doi-asserted-by":"publisher","unstructured":"Bai MF, Wang X. Risk factors associated with coronary heart disease in women: a systematic review. Herz. 2019. https:\/\/doi.org\/10.1007\/s00059-019-4835-2 PMID: 31317202.","DOI":"10.1007\/s00059-019-4835-2"},{"key":"2001_CR7","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/j.hlc.2018.06.1057","volume":"28","author":"M Tibaut","year":"2019","unstructured":"Tibaut M, Caprnda M, Kubatka P, Sinkovi\u010d A, Valentova V, Filipova S, et al. Markers of Atherosclerosis: Part 1 - Serological Markers. Heart Lung Circ. 2019;28:667\u201377. https:\/\/doi.org\/10.1016\/j.hlc.2018.06.1057 PMID: 30468147.","journal-title":"Heart Lung Circ"},{"key":"2001_CR8","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/S1474-4422(09)70127-9","volume":"8","author":"H Chabriat","year":"2009","unstructured":"Chabriat H, Joutel A, Dichgans M, Tournier-Lasserve E, Bousser MG. Cadasil. Lancet Neurol. 2009;8:643\u201353. https:\/\/doi.org\/10.1016\/S1474-4422(09)70127-9 PMID: 19539236.","journal-title":"Lancet Neurol"},{"key":"2001_CR9","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1212\/WNL.0000000000003251","volume":"87","author":"M Bugiani","year":"2016","unstructured":"Bugiani M, Kevelam SH, Bakels HS, Waisfisz Q, Ceuterick-de Groote C, Niessen HW, et al. Cathepsin A-related arteriopathy with strokes and leukoencephalopathy (CARASAL). Neurology. 2016;87:1777\u201386. https:\/\/doi.org\/10.1212\/WNL.0000000000003251 PMID: 27664989.","journal-title":"Neurology"},{"key":"2001_CR10","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1212\/WNL.0000000000001027","volume":"83","author":"S Debette","year":"2014","unstructured":"Debette S, Goeggel Simonetti B, Schilling S, Martin JJ, Kloss M, Sarikaya H, et al. Familial occurrence and heritable connective tissue disorders in cervical artery dissection. Neurology. 2014;83:2023\u201331. https:\/\/doi.org\/10.1212\/WNL.0000000000001027 PMID: 25355833.","journal-title":"Neurology"},{"key":"2001_CR11","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1002\/ags3.12179","volume":"2","author":"H Shimada","year":"2018","unstructured":"Shimada H. p53 molecular approach to diagnosis and treatment of esophageal squamous cell carcinoma. Ann Gastroenterol Surg. 2018;2:266\u201373. https:\/\/doi.org\/10.1002\/ags3.12179 PMID: 30003189.","journal-title":"Ann Gastroenterol Surg"},{"key":"2001_CR12","doi-asserted-by":"publisher","first-page":"1914","DOI":"10.1073\/pnas.94.5.1914","volume":"94","author":"YT Chen","year":"1997","unstructured":"Chen YT, Scanlan MJ, Sahin U, T\u00fcreci O, Gure AO, Tsang S, et al. A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening. Proc Natl Acad Sci U S A. 1997;94:1914\u20138. https:\/\/doi.org\/10.1073\/pnas.94.5.1914 PMID: 9050879.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2001_CR13","doi-asserted-by":"publisher","first-page":"2635","DOI":"10.7314\/apjcp.2014.15.6.2635","volume":"15","author":"JJ Qin","year":"2014","unstructured":"Qin JJ, Wang XR, Wang P, Ren PF, Shi JX, Zhang HF, et al. Mini-array of multiple tumor-associated antigens (TAAs) in the immunodiagnosis of esophageal cancer. Asian Pac J Cancer Prev. 2014;15:2635\u201340. https:\/\/doi.org\/10.7314\/apjcp.2014.15.6.2635 PMID: 24761876.","journal-title":"Asian Pac J Cancer Prev"},{"key":"2001_CR14","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/978-981-13-7295-7_3","volume-title":"Biomarkers in Cancer Therapy (ISBN: 978-981-13-7295-7)","author":"T Hiwasa","year":"2019","unstructured":"Hiwasa T, Shimada H. Autoantibody in cancer. In: Shimada H, editor. Biomarkers in Cancer Therapy (ISBN: 978-981-13-7295-7). Singapore: Springer Nature; 2019. p. 25\u201340. https:\/\/doi.org\/10.1007\/978-981-13-7295-7_3."},{"key":"2001_CR15","doi-asserted-by":"publisher","first-page":"2648","DOI":"10.1161\/01.str.31.11.2648","volume":"31","author":"J Kramer","year":"2000","unstructured":"Kramer J, Harcos P, Proh\u00e1szka Z, Horv\u00e1th L, Kar\u00e1di I, Singh M, et al. Frequencies of certain complement protein alleles and serum levels of anti-heat-shock protein antibodies in cerebrovascular diseases. Stroke. 2000;31:2648\u201352. https:\/\/doi.org\/10.1161\/01.str.31.11.2648 PMID: 11062289.","journal-title":"Stroke"},{"key":"2001_CR16","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1126\/science.6362005","volume":"222","author":"JP Palmer","year":"1983","unstructured":"Palmer JP, Asplin CM, Clemons P, Lyen K, Tatpati O, Raghu PK, et al. Insulin antibodies in insulin-dependent diabetics before insulin treatment. Science. 1983;222:1337\u20139. https:\/\/doi.org\/10.1126\/science.6362005 PMID: 6362005.","journal-title":"Science"},{"key":"2001_CR17","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/347151a0","volume":"347","author":"S Baekkeskov","year":"1990","unstructured":"Baekkeskov S, Aanstoot H, Christgau S, Reetz A, Solimena M, Cascalho M, et al. Identification of the 64\u2009K autoantigen in insulin dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase. Nature. 1990;347:151\u20136. https:\/\/doi.org\/10.1038\/347151a0 PMID: 1697648.","journal-title":"Nature"},{"key":"2001_CR18","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1172\/JCI118188","volume":"96","author":"MA Payton","year":"1995","unstructured":"Payton MA, Hawkes CJ, Christie MR. Relationship of the 37,000- and 40,000-M(r) tryptic fragments of islet antigens in insulin-dependent diabetes to the protein tyrosine phosphatase-like molecule IA-2 (ICA512). J Clin Invest. 1995;96:1506\u201311. https:\/\/doi.org\/10.1172\/JCI118188 PMID: 7657822.","journal-title":"J Clin Invest"},{"key":"2001_CR19","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1080\/08916930701619169","volume":"41","author":"CE Taplin","year":"2008","unstructured":"Taplin CE, Barker JM. Autoantibodies in type 1 diabetes. Autoimmunity. 2008;41:11\u20138. https:\/\/doi.org\/10.1080\/08916930701619169 PMID: 18176860.","journal-title":"Autoimmunity"},{"key":"2001_CR20","doi-asserted-by":"publisher","first-page":"2462","DOI":"10.3899\/jrheum.090188","volume":"36","author":"KP Liang","year":"2009","unstructured":"Liang KP, Kremers HM, Crowson CS, Snyder MR, Therneau TM, Roger VL, et al. Autoantibodies and the risk of cardiovascular events. J Rheumatol. 2009;36:2462\u20139. https:\/\/doi.org\/10.3899\/jrheum.090188 PMID: 19833748.","journal-title":"J Rheumatol"},{"key":"2001_CR21","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1093\/eurheartj\/ehq521","volume":"32","author":"F Montecucco","year":"2011","unstructured":"Montecucco F, Vuilleumier N, Pagano S, Lenglet S, Bertolotto M, Braunersreuther V, et al. Anti-apolipoprotein A-1 auto-antibodies are active mediators of atherosclerotic plaque vulnerability. Eur Heart J. 2011;32:412\u201321. https:\/\/doi.org\/10.1093\/eurheartj\/ehq521 PMID: 21224292.","journal-title":"Eur Heart J"},{"key":"2001_CR22","doi-asserted-by":"publisher","first-page":"342","DOI":"10.2174\/1389450115666141125122416","volume":"16","author":"N Satta","year":"2015","unstructured":"Satta N, Vuilleumier N. Auto-antibodies as possible markers and mediators of ischemic, dilated, and rhythmic cardiopathies. Curr Drug Targets. 2015;16:342\u201360. https:\/\/doi.org\/10.2174\/1389450115666141125122416 PMID: 25429713.","journal-title":"Curr Drug Targets"},{"key":"2001_CR23","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1590\/s0482-50042010000500007","volume":"50","author":"J Fesmire","year":"2010","unstructured":"Fesmire J, Wolfson-Reichlin M, Reichlin M. Effects of autoimmune antibodies anti-lipoprotein lipase, anti-low density lipoprotein, and anti-oxidized low density lipoprotein on lipid metabolism and atherosclerosis in systemic lupus erythematosus. Rev Bras Reumatol. 2010;50:539\u201351. https:\/\/doi.org\/10.1590\/s0482-50042010000500007 PMID: 21125190.","journal-title":"Rev Bras Reumatol"},{"issue":"05","key":"2001_CR24","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1160\/TH12-10-0768","volume":"109","author":"F Carbone","year":"2013","unstructured":"Carbone F, Nencioni A, Mach F, Vuilleumier N, Montecucco F. Evidence on the pathogenic role of auto-antibodies in acute cardiovascular diseases. Thromb Haemost. 2013;109(05):854\u201368. 23446994. https:\/\/doi.org\/10.1160\/TH12-10-0768.","journal-title":"Thromb Haemost."},{"key":"2001_CR25","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1002\/ijc.20517","volume":"112","author":"K Nakashima","year":"2004","unstructured":"Nakashima K, Shimada H, Ochiai T, Kuboshima M, Kuroiwa N, Okazumi S, et al. Serological identification of TROP2 by recombinant cDNA expression cloning using sera of patients with esophageal squamous cell carcinoma. Int J Cancer. 2004;112:1029\u201335. https:\/\/doi.org\/10.1002\/ijc.20517 PMID: 15386348.","journal-title":"Int J Cancer"},{"key":"2001_CR26","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1111\/j.1349-7006.2006.00192.x","volume":"97","author":"M Kuboshima","year":"2006","unstructured":"Kuboshima M, Shimada H, Liu TL, Nomura F, Takiguchi M, Hiwasa T, et al. Presence of serum tripartite motif-containing 21 antibodies in patients with esophageal squamous cell carcinoma. Cancer Sci. 2006;97:380\u20136. https:\/\/doi.org\/10.1111\/j.1349-7006.2006.00192.x PMID: 16630135.","journal-title":"Cancer Sci"},{"issue":"1","key":"2001_CR27","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1186\/1471-2407-9-232","volume":"9","author":"H Shimada","year":"2009","unstructured":"Shimada H, Shiratori T, Yasuraok M, Kagaya A, Kuboshima M, Nomura F, et al. Identification of Makorin 1 as a novel SEREX antigen of esophageal squamous cell carcinoma. BMC Cancer. 2009;9(1):232. https:\/\/doi.org\/10.1186\/1471-2407-9-232. PMID: 19604354.","journal-title":"BMC Cancer."},{"issue":"1","key":"2001_CR28","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/1477-5956-9-31","volume":"9","author":"A Kagaya","year":"2011","unstructured":"Kagaya A, Shimada H, Shiratori T, Kuboshima M, Nakashima-Fujita K, Yasuraoka M, et al. Identification of a novel SEREX antigen family, ECSA, in esophageal squamous cell carcinoma. Proteome Sci. 2011;9(1):31. https:\/\/doi.org\/10.1186\/1477-5956-9-31. PMID: 21696638.","journal-title":"Proteome Sci."},{"key":"2001_CR29","doi-asserted-by":"publisher","first-page":"82493","DOI":"10.18632\/oncotarget.12696","volume":"7","author":"S Kobayashi","year":"2016","unstructured":"Kobayashi S, Hoshino T, Hiwasa T, Satoh M, Rahmutulla B, Tsuchida S, et al. Anti-FIRs (PUF60) auto-antibodies are detected in the sera of early-stage colon cancer patients. Oncotarget. 2016;7:82493\u2013503. https:\/\/doi.org\/10.18632\/oncotarget.12696 PMID: 27756887.","journal-title":"Oncotarget"},{"key":"2001_CR30","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/1756-9966-31-85","volume":"31","author":"T Matsutani","year":"2012","unstructured":"Matsutani T, Hiwasa T, Takiguchi M, Oide T, Kunimatsu M, Saeki N, et al. Autologous antibody to src-homology 3-domain GRB2-like 1 specifically increases in the sera of patients with low-grade gliomas. J Exp Clin Cancer Res. 2012;31:85. https:\/\/doi.org\/10.1186\/1756-9966-31-85 PMID: 23050879.","journal-title":"J Exp Clin Cancer Res"},{"issue":"1","key":"2001_CR31","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1186\/1471-2407-14-452","volume":"14","author":"M Adachi-Hayama","year":"2014","unstructured":"Adachi-Hayama M, Adachi A, Shinozaki N, Matsutani T, Hiwasa T, Takiguchi M, et al. Circulating anti-filamin C antibody as a potential serum biomarker for low-grade gliomas. BMC Cancer. 2014;14(1):452. https:\/\/doi.org\/10.1186\/1471-2407-14-452.","journal-title":"BMC Cancer."},{"key":"2001_CR32","doi-asserted-by":"publisher","first-page":"106206","DOI":"10.18632\/oncotarget.22175","volume":"8","author":"K Hontani","year":"2017","unstructured":"Hontani K, Tsuchikawa T, Hiwasa T, Nakamura T, Ueno T, Kushibiki T, et al. Identification of novel serum autoantibodies against EID3 in non-functional pancreatic neuroendocrine tumors. Oncotarget. 2017;8:106206\u201321. https:\/\/doi.org\/10.18632\/oncotarget.22175 PMID: 29290942.","journal-title":"Oncotarget"},{"key":"2001_CR33","doi-asserted-by":"publisher","first-page":"1975","DOI":"10.1111\/jgh.14297","volume":"33","author":"S Hamanaka","year":"2018","unstructured":"Hamanaka S, Nakagawa T, Hiwasa T, Ohta Y, Kasamatsu S, Ishigami H, et al. Investigation of novel biomarkers for predicting the clinical course in patients with ulcerative colitis. J Gastroenterol Hepatol. 2018;33:1975\u201383. https:\/\/doi.org\/10.1111\/jgh.14297 PMID: 29869393.","journal-title":"J Gastroenterol Hepatol"},{"key":"2001_CR34","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.jneuroim.2015.05.005","volume":"284","author":"M Muto","year":"2015","unstructured":"Muto M, Mori M, Hiwasa T, Takiguchi M, Iwadate Y, Uzawa A, et al. Novel serum autoantibodies against talin1 in multiple sclerosis: Possible pathogenetic roles of the antibodies. J Neuroimmunol. 2015;284:30\u20136. https:\/\/doi.org\/10.1016\/j.jneuroim.2015.05.005 PMID: 26025055.","journal-title":"J Neuroimmunol"},{"key":"2001_CR35","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.jneuroim.2018.09.013","volume":"325","author":"K Sugimoto","year":"2018","unstructured":"Sugimoto K, Hiwasa T, Shibuya K, Hirano S, Beppu M, Isose S, et al. Novel autoantibodies against the proteasome subunit PMSA7 in amyotrophic lateral sclerosis. J Neuroimmunol. 2018;325:54\u201360. https:\/\/doi.org\/10.1016\/j.jneuroim.2018.09.013 PMID: 30390597.","journal-title":"J Neuroimmunol"},{"key":"2001_CR36","doi-asserted-by":"publisher","first-page":"e0195015","DOI":"10.1371\/journal.pone.0195015","volume":"13","author":"T Matsumura","year":"2018","unstructured":"Matsumura T, Terada J, Kinoshita T, Sakurai Y, Yahaba M, Tsushima K, et al. Autoantibody against NBL1 in obstructive sleep apnea patients with cardiovascular disease. PLoS One. 2018;13:e0195015. https:\/\/doi.org\/10.1371\/journal.pone.0195015 PMID: 29596467.","journal-title":"PLoS One"},{"key":"2001_CR37","doi-asserted-by":"publisher","first-page":"71","DOI":"10.3390\/diagnostics10020071","volume":"10","author":"Y Katsumata","year":"2020","unstructured":"Katsumata Y, Terada J, Matsumura T, Koshikawa K, Sakao S, Tomiyoshi G, et al. Circulating anti-sorting nexins 16 antibodies as an emerging biomarker of coronary artery disease in patients with obstructive sleep apnea. Diagnostics. 2020;10:71. https:\/\/doi.org\/10.3390\/diagnostics10020071 PMID: 32012743.","journal-title":"Diagnostics"},{"key":"2001_CR38","doi-asserted-by":"publisher","first-page":"e0211377","DOI":"10.1371\/journal.pone.0211377","volume":"14","author":"A Naito","year":"2019","unstructured":"Naito A, Hiwasa T, Tanabe N, Jujo-Sanada T, Sugiura T, Shigeta A, et al. Elevated levels of autoantibodies against EXD2 and PHAX in the sera of patients with chronic thromboembolic pulmonary hypertension. PLoS One. 2019;14:e0211377. https:\/\/doi.org\/10.1371\/journal.pone.0211377 PMID: 30759165.","journal-title":"PLoS One"},{"key":"2001_CR39","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s12967-015-0393-4","volume":"13","author":"T Machida","year":"2015","unstructured":"Machida T, Kubota M, Kobayashi E, Iwadate Y, Saeki N, Yamaura A, et al. Identification of stroke-associated-antigens via screening of recombinant proteins from the human expression cDNA library (SEREX). J Translat Med. 2015;13:71. https:\/\/doi.org\/10.1186\/s12967-015-0393-4 PMID: 25890248.","journal-title":"J Translat Med"},{"key":"2001_CR40","doi-asserted-by":"publisher","first-page":"8836","DOI":"10.18632\/oncotarget.23653","volume":"9","author":"Y Yoshida","year":"2018","unstructured":"Yoshida Y, Wang H, Hiwasa T, Machida T, Kobayashi E, Mine S, et al. Elevation of autoantibody level against PDCD11 in patients with transient ischemic attack. Oncotarget. 2018;9:8836\u201348. https:\/\/doi.org\/10.18632\/oncotarget.23653 PMID: 29507658.","journal-title":"Oncotarget"},{"key":"2001_CR41","doi-asserted-by":"publisher","first-page":"5600","DOI":"10.18632\/oncotarget.23789","volume":"9","author":"H Wang","year":"2018","unstructured":"Wang H, Zhang XM, Tomiyoshi G, Nakamura R, Shinmen N, Kuroda H, et al. Association of serum levels of antibodies against MMP1, CBX1, and CBX5 with transient ischemic attack and cerebral infarction. Oncotarget. 2018;9:5600\u201313. https:\/\/doi.org\/10.18632\/oncotarget.23789 PMID: 29464021.","journal-title":"Oncotarget"},{"key":"2001_CR42","doi-asserted-by":"publisher","first-page":"e04661","DOI":"10.1016\/j.heliyon.2020.e04661","volume":"6","author":"Y Yoshida","year":"2020","unstructured":"Yoshida Y, Zhang XM, Wang H, Machida T, Mine S, Kobayashi E, et al. Elevated levels of autoantibodies against DNAJC2 in sera of patients with atherosclerotic diseases. Heliyon. 2020;6:e04661. https:\/\/doi.org\/10.1016\/j.heliyon.2020.e04661 PMID: 32904265.","journal-title":"Heliyon"},{"key":"2001_CR43","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.3892\/ijmm.2020.4690","volume":"46","author":"SY Li","year":"2020","unstructured":"Li SY, Yoshida Y, Kobayashi E, Adachi A, Hirono S, Matsutani T, et al. Association between serum anti-ASXL2 antibody levels and acute ischemic stroke, acute myocardial infarction, diabetes mellitus, chronic kidney disease and digestive organ cancer, and their possible association with atherosclerosis and hypertension. Int J Mol Med. 2020;46:1274\u201388. https:\/\/doi.org\/10.3892\/ijmm.2020.4690 PMID: 32945427.","journal-title":"Int J Mol Med"},{"key":"2001_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ijcard.2017.04.047","volume":"243","author":"PM Chen","year":"2017","unstructured":"Chen PM, Ohno M, Hiwasa T, Nishi K, Saijo S, Sakamoto J, et al. Nardilysin is a promising biomarker for the early diagnosis of acute coronary syndrome. Int J Cardiol. 2017;243:1\u20138. https:\/\/doi.org\/10.1016\/j.ijcard.2017.04.047 PMID: 28747015.","journal-title":"Int J Cardiol"},{"key":"2001_CR45","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1161\/01.str.24.1.35","volume":"24","author":"HP Adams Jr","year":"1993","unstructured":"Adams HP Jr, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke. 1993;24:35\u201341. https:\/\/doi.org\/10.1161\/01.str.24.1.35 PMID: 7678184.","journal-title":"Stroke"},{"key":"2001_CR46","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1159\/000157629","volume":"29","author":"R Nishiura","year":"2009","unstructured":"Nishiura R, Fujimoto S, Sato Y, Yamada K, Hisanaga S, Hara S, et al. Elevated osteoprotegerin levels predict cardiovascular events in new hemodialysis patients. Am J Nephrol. 2009;29:257\u201363. https:\/\/doi.org\/10.1159\/000157629 PMID: 18802328.","journal-title":"Am J Nephrol"},{"key":"2001_CR47","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1159\/000197116","volume":"30","author":"H Komatsu","year":"2009","unstructured":"Komatsu H, Fujimoto S, Hara S, Fukuda A, Fukudome K, Yamada K, et al. Recent therapeutic strategies improve renal outcome in patients with IgA nephropathy. Am J Nephrol. 2009;30:19\u201325. https:\/\/doi.org\/10.1159\/000197116 PMID: 19169006.","journal-title":"Am J Nephrol"},{"key":"2001_CR48","doi-asserted-by":"publisher","unstructured":"Goto K, Sugiyama T, Matsumura R, Zhang XM, Kimura R, Taira A, et al. Identification of cerebral infarction-specific antibody markers from autoantibodies detected in patients with systemic lupus erythematosus. J Mol Biomark Diagnos. 2015;6:\u20132. https:\/\/doi.org\/10.4172\/2155-9929.1000219.","DOI":"10.4172\/2155-9929.1000219"},{"key":"2001_CR49","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1002\/ibd.21508","volume":"17","author":"N Vermeulen","year":"2011","unstructured":"Vermeulen N, de B\u00e9eck KO, Vermeire S, Van Steen K, Michiels G, Ballet V, et al. Identification of a novel autoantigen in inflammatory bowel disease by protein microarray. Inflamm Bowel Dis. 2011;17:1291\u2013300. https:\/\/doi.org\/10.1002\/ibd.21508 PMID: 21560193.","journal-title":"Inflamm Bowel Dis"},{"key":"2001_CR50","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1263\/jbb.101.485","volume":"101","author":"R Kato","year":"2006","unstructured":"Kato R, Kaga C, Kunimatsu M, Kobayashi T, Honda H. Peptide array-based interaction assay of solid-bound peptides and anchorage-dependent cells and its effectiveness in cell-adhesive peptide design. J Biosci Bioeng. 2006;101:485\u201395. https:\/\/doi.org\/10.1263\/jbb.101.485 PMID: 16935250.","journal-title":"J Biosci Bioeng"},{"key":"2001_CR51","doi-asserted-by":"publisher","first-page":"132","DOI":"10.4172\/17457580.1000132","volume":"13","author":"T Hiwasa","year":"2017","unstructured":"Hiwasa T, Tomiyoshi G, Nakamura R, Shinmen N, Kuroda H, Kunimatsu M, et al. Serum SH3BP5-specific antibody level is a biomarker of atherosclerosis. Immunome Res. 2017;13:132. https:\/\/doi.org\/10.4172\/17457580.1000132.","journal-title":"Immunome Res."},{"key":"2001_CR52","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1093\/jjco\/hyu096","volume":"44","author":"S Tsugane","year":"2014","unstructured":"Tsugane S, Sawada N. The JPHC study: design and some findings on the typical Japanese diet. Jpn J Clin Oncol. 2014;44:777\u201382. https:\/\/doi.org\/10.1093\/jjco\/hyu096 PMID: 25104790.","journal-title":"Jpn J Clin Oncol"},{"issue":"1","key":"2001_CR53","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.atherosclerosis.2013.06.013","volume":"230","author":"A Ikeda","year":"2013","unstructured":"Ikeda A, Iso H, Sasazuki S, Inoue M, Tsugane S, JPHC Study Group. The combination of Helicobacter pylori- and cytotoxin-associated gene-A seropositivity in relation to the risk of myocardial infarction in middle-aged Japanese: The Japan Public Health Center-based study. Atherosclerosis. 2013;230(1):67\u201372. 23958254. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2013.06.013.","journal-title":"Atherosclerosis."},{"key":"2001_CR54","doi-asserted-by":"publisher","first-page":"097","DOI":"10.4172\/1745-7580.1000097","volume":"11","author":"T Hiwasa","year":"2015","unstructured":"Hiwasa T, Machida T, Zhang XM, Kimura R, Wang H, Iwase K, et al. Elevated levels of autoantibodies against ATP2B4 and BMP-1 in sera of patients with atherosclerosis-related diseases. Immunome Res. 2015;11:097. https:\/\/doi.org\/10.4172\/1745-7580.1000097.","journal-title":"Immunome Res"},{"key":"2001_CR55","first-page":"1001","volume":"1","author":"R Nakamura","year":"2017","unstructured":"Nakamura R, Tomiyoshi G, Shinmen N, Kuroda H, Kudo T, Doi H, et al. An anti-deoxyhypusine synthase antibody as a marker of atherosclerosis-related cerebral infarction, myocardial infarction, diabetes mellitus, and chronic kidney disease. SM Atheroscler J. 2017;1:1001. http:\/\/smjournals.com\/atherosclerosis\/in-press.php#x.","journal-title":"SM Atheroscler J"},{"key":"2001_CR56","doi-asserted-by":"publisher","first-page":"49","DOI":"10.18314\/gjbs.v1i2.27","volume":"1","author":"T Hiwasa","year":"2015","unstructured":"Hiwasa T, Zhang XM, Kimura R, Machida T, Kitamura K, Yamazoe R, et al. Association of serum antibody levels against TUBB2C with diabetes and cerebral infarction. Integ Biomed Sci. 2015;1:49\u201363. https:\/\/doi.org\/10.18314\/gjbs.v1i2.27.","journal-title":"Integ Biomed Sci"},{"issue":"12","key":"2001_CR57","doi-asserted-by":"publisher","first-page":"4453","DOI":"10.1111\/cas.14652","volume":"111","author":"M Sumazaki","year":"2020","unstructured":"Sumazaki M, Shimada H, Ito M, Shiratori F, Kobayashi E, Yoshida Y, et al. Serum anti-LRPAP1 is a common biomarker for digestive organ cancers and atherosclerotic diseases. Cancer Sci. 2020;111(12):4453\u201364. 32939876. https:\/\/doi.org\/10.1111\/cas.14652.","journal-title":"Cancer Sci."},{"key":"2001_CR58","doi-asserted-by":"publisher","first-page":"303","DOI":"10.2176\/nmc.ra.2018-0022","volume":"58","author":"Y Yoshida","year":"2018","unstructured":"Yoshida Y, Hiwasa T, Machida T, Kobayashi E, Mine S, Matsushima J, et al. Elevation of autoantibody in patients with ischemic stroke. Neurol Med Chir (Tokyo). 2018;58:303\u201310. https:\/\/doi.org\/10.2176\/nmc.ra.2018-0022 PMID: 29848906.","journal-title":"Neurol Med Chir (Tokyo)"},{"issue":"04","key":"2001_CR59","doi-asserted-by":"publisher","first-page":"358","DOI":"10.4172\/2161-0460.1000358","volume":"7","author":"K Sugimoto","year":"2017","unstructured":"Sugimoto K, Tomiyoshi G, Mori M, Kuwabara S, Hirano S, Sawai S, et al. Identification of serum anti-GADD34 antibody as a common marker of diabetes mellitus and Parkinson disease. J Alzheimers Dis Parkinsonism. 2017;7(04):358. https:\/\/doi.org\/10.4172\/2161-0460.1000358.","journal-title":"J Alzheimers Dis Parkinsonism."},{"issue":"06","key":"2001_CR60","doi-asserted-by":"publisher","first-page":"361","DOI":"10.4172\/2155-9929.1000361","volume":"8","author":"XM Zhang","year":"2017","unstructured":"Zhang XM, Wang H, Mine S, Takemoto M, Yokote K, Kitamura K, et al. Association of serum anti-prolylcarboxypeptidase antibody marker with atherosclerotic diseases accompanied by hypertension. J Mol Biomark Diagn. 2017;8(06):361. https:\/\/doi.org\/10.4172\/2155-9929.1000361.","journal-title":"J Mol Biomark Diagn."},{"issue":"1","key":"2001_CR61","first-page":"36","volume":"30","author":"F Wolfe","year":"2003","unstructured":"Wolfe F, Freundlich B, Straus WL. Increase in cardiovascular and cerebrovascular disease prevalence in rheumatoid arthritis. J Rheumatol. 2003;30(1):36\u201340. 12508387.","journal-title":"J Rheumatol."},{"key":"2001_CR62","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/nrrheum.2011.75","volume":"7","author":"DP Symmons","year":"2011","unstructured":"Symmons DP, Gabriel SE. Epidemiology of CVD in rheumatic disease, with a focus on RA and SLE. Nat Rev Rheumatol. 2011;7:399\u2013408. https:\/\/doi.org\/10.1038\/nrrheum.2011.75 PMID: 21629241.","journal-title":"Nat Rev Rheumatol"},{"key":"2001_CR63","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12016-018-8714-z","volume":"58","author":"F Carbone","year":"2020","unstructured":"Carbone F, Bonaventura A, Liberale L, Paolino S, Torre F, Dallegri F, et al. Atherosclerosis in rheumatoid arthritis: promoters and opponents. Clin Rev Allergy Immunol. 2020;58:1\u201314. https:\/\/doi.org\/10.1007\/s12016-018-8714-z PMID: 30259381.","journal-title":"Clin Rev Allergy Immunol"},{"key":"2001_CR64","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1111\/1756-185X.13309","volume":"21","author":"M Sanjadi","year":"2018","unstructured":"Sanjadi M, Rezvanie Sichanie Z, Totonchi H, Karami J, Rezaei R, Aslani S. Atherosclerosis and autoimmunity: a growing relationship. Int J Rheum Dis. 2018;21:908\u201321. https:\/\/doi.org\/10.1111\/1756-185X.13309 PMID: 29671956.","journal-title":"Int J Rheum Dis"},{"key":"2001_CR65","doi-asserted-by":"publisher","first-page":"393","DOI":"10.5664\/jcsm.6488","volume":"13","author":"T Matsumura","year":"2017","unstructured":"Matsumura T, Terada J, Kinoshita T, Sakurai Y, Yahaba M, Ema R, et al. Circulating anti-coatomer protein complex subunit epsilon (COPE) autoantibodies as a potential biomarker for cardio- and cerebro-vascular events in patients with obstructive sleep apnea. J Clin Sleep Med. 2017;13:393\u2013400. https:\/\/doi.org\/10.5664\/jcsm.6488 PMID: 27923433.","journal-title":"J Clin Sleep Med"},{"key":"2001_CR66","doi-asserted-by":"publisher","first-page":"e113086","DOI":"10.1371\/journal.pone.0113086","volume":"9","author":"A Naito","year":"2014","unstructured":"Naito A, Tanabe N, Jujo T, Shigeta A, Sugiura T, Sakao S, et al. Pentraxin3 in chronic thromboembolic pulmonary hypertension: a new biomarker for screening from remitted pulmonary thromboembolism. PLoS One. 2014;9:e113086. https:\/\/doi.org\/10.1371\/journal.pone.0113086 PMID: 25412085.","journal-title":"PLoS One"},{"issue":"7","key":"2001_CR67","doi-asserted-by":"publisher","first-page":"680","DOI":"10.5551\/jat.11767","volume":"19","author":"LT Tran","year":"2012","unstructured":"Tran LT, Park HJ, Kim HD. Is the carotid intima-media thickness really a good surrogate marker of atherosclerosis? J Atheroscler Thromb. 2012;19(7):680\u201390. 22653163. https:\/\/doi.org\/10.5551\/jat.11767.","journal-title":"J Atheroscler Thromb."},{"issue":"6","key":"2001_CR68","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1161\/01.atv.20.6.1622","volume":"20","author":"M Zureik","year":"2000","unstructured":"Zureik M, Ducimeti\u00e8re P, Touboul PJ, Courbon D, Bonithon-Kopp C, Berr C, et al. Common carotid intima-media thickness predicts occurrence of carotid atherosclerotic plaques: longitudinal results from the Aging Vascular Study (EVA) study. Arterioscler Thromb Vasc Biol. 2000;20(6):1622\u20139. 10845881. https:\/\/doi.org\/10.1161\/01.atv.20.6.1622.","journal-title":"Arterioscler Thromb Vasc Biol."},{"issue":"2","key":"2001_CR69","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.atherosclerosis.2011.08.007","volume":"220","author":"T Koivistoinen","year":"2012","unstructured":"Koivistoinen T, Virtanen M, Hutri-K\u00e4h\u00f6nen N, Lehtim\u00e4ki T, Jula A, Juonala M, et al. Arterial pulse wave velocity in relation to carotid intima-media thickness, brachial flow-mediated dilation and carotid artery distensibility: the Cardiovascular Risk in Young Finns Study and the Health 2000 Survey. Atherosclerosis. 2012;220(2):387\u201393. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2011.08.007. PMID: 21871623.","journal-title":"Atherosclerosis."},{"issue":"3","key":"2001_CR70","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1161\/01.str.28.3.518","volume":"28","author":"T Mannami","year":"1997","unstructured":"Mannami T, Konishi M, Baba S, Nishi N, Terao A. Prevalence of asymptomatic carotid atherosclerotic lesions detected by high-resolution ultrasonography and its relation to cardiovascular risk factors in the general population of a Japanese city: the Suita study. Stroke. 1997;28(3):518\u201325. https:\/\/doi.org\/10.1161\/01.str.28.3.518. PMID: 9056605.","journal-title":"Stroke."},{"key":"2001_CR71","doi-asserted-by":"publisher","first-page":"7992","DOI":"10.1073\/pnas.96.14.7992","volume":"96","author":"D Garcia-Domingo","year":"1999","unstructured":"Garcia-Domingo D, Leonardo E, Grandien A, Martinez P, Albar JP, Izpisua-Belmonte JC, et al. DIO-1 is a gene involved in onset of apoptosis in vitro, whose misexpression disrupts limb development. Proc Nat Acad Sci USA. 1999;96:7992\u20137. https:\/\/doi.org\/10.1073\/pnas.96.14.7992 PMID: 10393935.","journal-title":"Proc Nat Acad Sci USA"},{"key":"2001_CR72","doi-asserted-by":"publisher","first-page":"12909","DOI":"10.1074\/jbc.275.17.12909","volume":"275","author":"C P\u00e9rez-S\u00e1nchez","year":"2000","unstructured":"P\u00e9rez-S\u00e1nchez C, G\u00f3mez-Ferrer\u00eda MA, de La Fuente CA, Granadino B, Velasco G, Esteban-Gamboa A, et al. FHX, a novel fork head factor with a dual DNA binding specificity. J Biol Chem. 2000;275:12909\u201316. https:\/\/doi.org\/10.1074\/jbc.275.17.12909 PMID: 10777590.","journal-title":"J Biol Chem"},{"key":"2001_CR73","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1186\/s12885-018-4265-1","volume":"18","author":"LC Soriano","year":"2018","unstructured":"Soriano LC, Soriano-Gabarr\u00f3 M, Garc\u00eda Rodr\u00edguez LA. Trends in the contemporary incidence of colorectal cancer and patient characteristics in the United Kingdom: a population-based cohort study using The Health Improvement Network. BMC Cancer. 2018;18:402. https:\/\/doi.org\/10.1186\/s12885-018-4265-1 PMID: 29636012.","journal-title":"BMC Cancer"},{"key":"2001_CR74","doi-asserted-by":"publisher","first-page":"1800081","DOI":"10.1183\/13993003.00081-2018","volume":"53","author":"J Qian","year":"2019","unstructured":"Qian J, Li M, Zhang X, Wang Q, Zhao J, Tian Z, et al. Long-term prognosis of patients with systemic lupus erythematosus-associated pulmonary arterial hypertension: CSTAR-PAH cohort study. Eur Respir J. 2019;53:1800081. https:\/\/doi.org\/10.1183\/13993003.00081-2018 PMID: 30635295.","journal-title":"Eur Respir J"},{"key":"2001_CR75","doi-asserted-by":"publisher","first-page":"2672","DOI":"10.1101\/gad.9.21.2672","volume":"9","author":"KGK Murthy","year":"1995","unstructured":"Murthy KGK, Manley JL. The 160-kD subunit of human cleavage-polyadenylation specificity factor coordinates pre-mRNA 3-prime-end formation. Genes Dev. 1995;9:2672\u201383. https:\/\/doi.org\/10.1101\/gad.9.21.2672 PMID: 7590244.","journal-title":"Genes Dev"},{"key":"2001_CR76","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1016\/j.febslet.2012.04.030","volume":"586","author":"J Cai","year":"2012","unstructured":"Cai J, Pardali E, S\u00e1nchez-Duffhues G, ten Dijke P. BMP signaling in vascular diseases. FEBS Lett. 2012;586:1993\u20132002. https:\/\/doi.org\/10.1016\/j.febslet.2012.04.030 PMID: 22710160.","journal-title":"FEBS Lett"},{"key":"2001_CR77","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/j.tem.2014.05.003","volume":"25","author":"LA Dyer","year":"2014","unstructured":"Dyer LA, Pi X, Patterson C. The role of BMPs in endothelial cell function and dysfunction. Trends Endocrinol Metab. 2014;25:472\u201380. https:\/\/doi.org\/10.1016\/j.tem.2014.05.003 PMID: 24908616.","journal-title":"Trends Endocrinol Metab"},{"key":"2001_CR78","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.1161\/hq1201.100229","volume":"21","author":"CR Dhore","year":"2001","unstructured":"Dhore CR, Cleutjens JP, Lutgens E, Cleutjens KB, Geusens PP, Kitslaar PJ, et al. Differential expression of bone matrix regulatory proteins in human atherosclerotic plaques. Arterioscler Thromb Vasc Biol. 2001;21:1998\u20132003. https:\/\/doi.org\/10.1161\/hq1201.100229 PMID: 11742876.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2001_CR79","doi-asserted-by":"publisher","first-page":"31128","DOI":"10.1074\/jbc.M300703200","volume":"278","author":"GP Sorescu","year":"2003","unstructured":"Sorescu GP, Sykes M, Weiss D, Platt MO, Saha A, Hwang J, et al. Bone morphogenic protein 4 produced in endothelial cells by oscillatory shear stress stimulates an inflammatory response. J Biol Chem. 2003;278:31128\u201335. https:\/\/doi.org\/10.1074\/jbc.M300703200 PMID: 12766166.","journal-title":"J Biol Chem"},{"key":"2001_CR80","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s12933-015-0214-3","volume":"14","author":"M Zhang","year":"2015","unstructured":"Zhang M, Sara JD, Wang FL, Liu LP, Su LX, Zhe J, et al. Increased plasma BMP-2 levels are associated with atherosclerosis burden and coronary calcification in type 2 diabetic patients. Cardiovasc Diabetol. 2015;14:64. https:\/\/doi.org\/10.1186\/s12933-015-0214-3 PMID: 26003174.","journal-title":"Cardiovasc Diabetol"},{"key":"2001_CR81","doi-asserted-by":"publisher","first-page":"2818","DOI":"10.1161\/CIRCULATIONAHA.106.611822","volume":"113","author":"S Miriyala","year":"2006","unstructured":"Miriyala S, Gongora Nieto MC, Mingone C, Smith D, Dikalov S, Harrison DG, et al. Bone morphogenic protein-4 induces hypertension in mice: role of noggin, vascular NADPH oxidases, and impaired vasorelaxation. Circulation. 2006;113:2818\u201325. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.106.611822 PMID: 16769910.","journal-title":"Circulation"},{"key":"2001_CR82","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1161\/CIRCRESAHA.110.219071","volume":"107","author":"Y Yao","year":"2010","unstructured":"Yao Y, Bennett BJ, Wang X, Rosenfeld ME, Giachelli C, Lusis AJ, et al. Inhibition of bone morphogenetic proteins protects against atherosclerosis and vascular calcification. Circ Res. 2010;107:485\u201394. https:\/\/doi.org\/10.1161\/CIRCRESAHA.110.219071 PMID: 20576934.","journal-title":"Circ Res"},{"key":"2001_CR83","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1161\/ATVBAHA.111.242594","volume":"32","author":"M Derwall","year":"2012","unstructured":"Derwall M, Malhotra R, Lai CS, Beppu Y, Aikawa E, Seehra JS, et al. Inhibition of bone morphogenetic protein signaling reduces vascular calcification and atherosclerosis. Arterioscler Thromb Vasc Biol. 2012;32:613\u201322. https:\/\/doi.org\/10.1161\/ATVBAHA.111.242594 PMID: 22223731.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2001_CR84","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1161\/ATVBAHA.112.300287","volume":"33","author":"CW Kim","year":"2013","unstructured":"Kim CW, Song H, Kumar S, Nam D, Kwon HS, Chang KH, et al. Anti-inflammatory and antiatherogenic role of BMP receptor II in endothelial cells. Arterioscler Thromb Vasc Biol. 2013;33:1350\u20139. https:\/\/doi.org\/10.1161\/ATVBAHA.112.300287 PMID: 23559633.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2001_CR85","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1038\/onc.2012.115","volume":"32","author":"S Braig","year":"2013","unstructured":"Braig S, Bosserhoff AK. Death inducer-obliterator 1 (Dido1) is a BMP target gene and promotes BMP-induced melanoma progression. Oncogene. 2013;32:837\u201348. https:\/\/doi.org\/10.1038\/onc.2012.115 PMID: 22469980.","journal-title":"Oncogene"},{"key":"2001_CR86","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1111\/j.1365-2443.2005.00887.x","volume":"10","author":"C Collart","year":"2005","unstructured":"Collart C, Remacle JE, Barabino S, van Grunsven LA, Nelles L, Schellens A, et al. Smicl is a novel Smad interacting protein and cleavage and polyadenylation specificity factor associated protein. Genes Cells. 2005;10:897\u2013906. https:\/\/doi.org\/10.1111\/j.1365-2443.2005.00887.x PMID: 16115198.","journal-title":"Genes Cells"},{"key":"2001_CR87","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.cytogfr.2011.11.006","volume":"22","author":"A Conidi","year":"2011","unstructured":"Conidi A, Cazzola S, Beets K, Coddens K, Collart C, Cornelis F, et al. Few Smad proteins and many Smad-interacting proteins yield multiple functions and action modes in TGF\u03b2\/BMP signaling in vivo. Cytokine Growth Factor Rev. 2011;22:287\u2013300. https:\/\/doi.org\/10.1016\/j.cytogfr.2011.11.006 PMID: 22119658.","journal-title":"Cytokine Growth Factor Rev"},{"key":"2001_CR88","doi-asserted-by":"publisher","first-page":"4778","DOI":"10.1074\/jbc.M113.486290","volume":"289","author":"Y Liu","year":"2014","unstructured":"Liu Y, Kim H, Liang J, Lu W, Ouyang B, Liu D, et al. The death-inducer obliterator 1 (Dido1) gene regulates embryonic stem cell self-renewal. J Biol Chem. 2014;289:4778\u201386. https:\/\/doi.org\/10.1074\/jbc.M113.486290 PMID: 24347171.","journal-title":"J Biol Chem"},{"key":"2001_CR89","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1016\/j.stemcr.2017.02.013","volume":"8","author":"A F\u00fctterer","year":"2017","unstructured":"F\u00fctterer A, de Celis J, Navajas R, Almonacid L, Guti\u00e9rrez J, Talavera-Guti\u00e9rrez A, et al. DIDO as a switchboard that regulates self-renewal and differentiation in embryonic stem cells. Stem Cell Reports. 2017;8:1062\u201375. https:\/\/doi.org\/10.1016\/j.stemcr.2017.02.013 PMID: 28330622.","journal-title":"Stem Cell Reports"},{"key":"2001_CR90","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1093\/cvr\/cvy022","volume":"114","author":"S Allahverdian","year":"2018","unstructured":"Allahverdian S, Chaabane C, Boukais K, Francis GA, Bochaton-Piallat ML. Smooth muscle cell fate and plasticity in atherosclerosis. Cardiovasc Res. 2018;114:540\u201350. https:\/\/doi.org\/10.1093\/cvr\/cvy022 PMID: 29385543.","journal-title":"Cardiovasc Res"},{"key":"2001_CR91","doi-asserted-by":"publisher","first-page":"2225","DOI":"10.1093\/humrep\/dep191","volume":"24","author":"M Zuccotti","year":"2009","unstructured":"Zuccotti M, Merico V, Sacchi L, Bellone M, Brink TC, Stefanelli M, et al. Oct-4 regulates the expression of Stella and Foxj2 at the Nanog locus: implications for the developmental competence of mouse oocytes. Hum Reprod. 2009;24:2225\u201337. https:\/\/doi.org\/10.1093\/humrep\/dep191 PMID: 19477878.","journal-title":"Hum Reprod"},{"key":"2001_CR92","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1007\/s11248-008-9214-3","volume":"17","author":"F Mart\u00edn-de-Lara","year":"2008","unstructured":"Mart\u00edn-de-Lara F, S\u00e1nchez-Aparicio P, de la Fuente CA, Rey-Campos J. Biological effects of FoxJ2 over-expression. Transgenic Res. 2008;17:1131\u201341. https:\/\/doi.org\/10.1007\/s11248-008-9214-3 PMID: 18726704.","journal-title":"Transgenic Res"},{"key":"2001_CR93","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1002\/cbin.10680","volume":"41","author":"Q Yang","year":"2017","unstructured":"Yang Q, Cao X, Tao G, Zhou F, Zhao P, Shen Y, et al. Effects of FOXJ2 on TGF-\u03b21-induced epithelial-mesenchymal transition through Notch signaling pathway in non-small lung cancer. Cell Biol Int. 2017;41:79\u201383. https:\/\/doi.org\/10.1002\/cbin.10680 PMID: 27611107.","journal-title":"Cell Biol Int"},{"key":"2001_CR94","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.medici.2016.03.002","volume":"52","author":"R Radi\u0161auskas","year":"2016","unstructured":"Radi\u0161auskas R, Kuzmickien\u0117 I, Milinavi\u010dien\u0117 E, Everatt R. Hypertension, serum lipids and cancer risk: a review of epidemiological evidence. Medicina [Kaunas]. 2016;52:89\u201398. https:\/\/doi.org\/10.1016\/j.medici.2016.03.002 PMID: 27170481.","journal-title":"Medicina [Kaunas]"},{"key":"2001_CR95","doi-asserted-by":"publisher","first-page":"3733","DOI":"10.2147\/OTT.S134915","volume":"10","author":"Y Shan","year":"2017","unstructured":"Shan Y, Chang T, Shi S, Tang M, Bao L, Li L, et al. Foxj2 overexpression is associated with poor prognosis, progression, and metastasis in nasopharyngeal carcinoma. Onco Targets Ther. 2017;10:3733\u201341. https:\/\/doi.org\/10.2147\/OTT.S134915 PMID: 28769576.","journal-title":"Onco Targets Ther"},{"key":"2001_CR96","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.1158\/0008-5472.CAN-09-2161","volume":"70","author":"H Kaneda","year":"2010","unstructured":"Kaneda H, Arao T, Tanaka K, Tamura D, Aomatsu K, Kudo K, et al. FOXQ1 is overexpressed in colorectal cancer and enhances tumorigenicity and tumor growth. Cancer Res. 2010;70:2053\u201363. https:\/\/doi.org\/10.1158\/0008-5472.CAN-09-2161 PMID: 20145154.","journal-title":"Cancer Res"},{"key":"2001_CR97","doi-asserted-by":"publisher","first-page":"2449","DOI":"10.3892\/ijo.2015.2957","volume":"46","author":"Y Qiang","year":"2015","unstructured":"Qiang Y, Wang F, Yan S, Zhang H, Zhu L, Chen Z, et al. Abnormal expression of Forkhead Box J2 (FOXJ2) suppresses migration and invasion in extrahepatic cholangiocarcinoma and is associated with prognosis. Int J Oncol. 2015;46:2449\u201358. https:\/\/doi.org\/10.3892\/ijo.2015.2957 PMID: 25873280.","journal-title":"Int J Oncol"},{"key":"2001_CR98","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1038\/s41419-018-0976-0","volume":"9","author":"H Zhang","year":"2018","unstructured":"Zhang H, Tang QF, Sun MY, Zhang CY, Zhu JY, Shen YL, et al. ARHGAP9 suppresses the migration and invasion of hepatocellular carcinoma cells through up-regulating FOXJ2\/E-cadherin. Cell Death Dis. 2018;9:916. https:\/\/doi.org\/10.1038\/s41419-018-0976-0 PMID: 30206221.","journal-title":"Cell Death Dis"},{"key":"2001_CR99","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.prp.2015.01.005","volume":"211","author":"X Qiu","year":"2015","unstructured":"Qiu X, Ji B, Yang L, Huang Q, Shi W, Ding Z, et al. The role of FoxJ2 in the migration of human glioma cells. Pathol Res Pract. 2015;211:389\u201397. https:\/\/doi.org\/10.1016\/j.prp.2015.01.005 PMID: 25661068.","journal-title":"Pathol Res Pract"},{"key":"2001_CR100","doi-asserted-by":"publisher","first-page":"2729","DOI":"10.1002\/jcb.24146","volume":"113","author":"Y Wang","year":"2012","unstructured":"Wang Y, Yang S, Ni Q, He S, Zhao Y, Yuan Q, et al. Overexpression of forkhead box J2 can decrease the migration of breast cancer cells. J Cell Biochem. 2012;113:2729\u201337. https:\/\/doi.org\/10.1002\/jcb.24146 PMID: 22441887.","journal-title":"J Cell Biochem"},{"key":"2001_CR101","doi-asserted-by":"publisher","first-page":"E1173","DOI":"10.1210\/jc.2013-4140","volume":"99","author":"N Nilubol","year":"2014","unstructured":"Nilubol N, Boufraqech M, Zhang L, Kebebew E. Loss of CPSF2 expression is associated with increased thyroid cancer cellular invasion and cancer stem cell population, and more aggressive disease. J Clin Endocrinol Metab. 2014;99:E1173\u201382. https:\/\/doi.org\/10.1210\/jc.2013-4140 PMID: 24654752.","journal-title":"J Clin Endocrinol Metab"},{"key":"2001_CR102","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.lfs.2018.04.025","volume":"203","author":"Z Wang","year":"2018","unstructured":"Wang Z, Teng D, Li Y, Hu Z, Liu L, Zheng H. A six-gene-based prognostic signature for hepatocellular carcinoma overall survival prediction. Life Sci. 2018;203:83\u201391. https:\/\/doi.org\/10.1016\/j.lfs.2018.04.025 PMID: 29678742.","journal-title":"Life Sci"}],"container-title":["BMC Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-021-02001-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12916-021-02001-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-021-02001-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,9]],"date-time":"2021-06-09T04:14:18Z","timestamp":1623212058000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedicine.biomedcentral.com\/articles\/10.1186\/s12916-021-02001-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,9]]},"references-count":102,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["2001"],"URL":"https:\/\/doi.org\/10.1186\/s12916-021-02001-9","relation":{},"ISSN":["1741-7015"],"issn-type":[{"value":"1741-7015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,9]]},"assertion":[{"value":"12 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Local Ethical Review Board of the Chiba University Graduate School of Medicine (Chiba, Japan) as well as the review boards of the cooperating hospitals or institutes. Sera were collected from participants who had provided informed consent. The study was conducted in accordance with the principles of the Declaration of Helsinki (2013).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"This work was performed in collaboration with Fujikura Kasei Co., Ltd. and Celish FD Inc. RN, GT, NS, and HK are employees of Fujikura Kasei Co., Ltd., and TK and HD are employees of Celish Fd Inc.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"131"}}